Financial insights of BIOLQ

MyFinsight

For the quarter ending 2024-09-30, BIOLQ made $10,850K in revenue. -$1,299K in net income. Net profit margin of -11.97%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Income Statement	2024-09-30
Net revenue	10,850
Cost of revenue	6,468
Gross profit	4,382
Research and development expense, total	917
General and administrative expense, total	1,283
Selling and marketing expense, total	2,877
Operating expenses	5,077
Operating income (loss)	-695
Gain (loss) on foreign currency transactions	-69
Other income (loss), net	-47
Interest expense, net	-605
Nonoperating income (expense)	-721
Income (loss) from continuing operations before income taxes, noncontrolling interest	-1,416
Income tax (benefit)	12
Net loss	-1,428
Foreign currency translation adjustments	129
Comprehensive income (loss), net of tax, attributable to parent	-1,299

Basic eps	-0.04
Diluted eps	-0.04
Basic average shares	36,083,000
Diluted average shares	36,083,000